Miami, Florida
Alzheimer's medication trials in Miami, FL
14 Alzheimer's medication studies are recruiting participants at sites in Miami as of November 17, 2026, according to ClinicalTrials.gov. Alzheimer's Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Miami at a glance
- 14 studies are recruiting at a site in Miami.
- By phase: Phase 2 (6), Phase 2/3 (1), Phase 3 (6), Phase 4 (1).
- By sponsor: industry (14).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Miami
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study sites
- A & D Doctor Center · Allied Biomedical Research Institute · Angels Clinical Research Institute - Miami
- Registry record
- NCT05980949 · updated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Nuovida Research Center
- Registry record
- NCT06937229 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study sites
- ABBA Medical Group LLC · Advanced Clinical Research Network, Corp · Future Care Solution, LLC
- Registry record
- NCT06159673 · updated
Flutemetamol F 18 Injection Formulation Comparison
- Phase 2
- Ages 50 to 110
- All sexes
- Sponsor
- GE Healthcare
- Study site
- Visionary Investigator Network
- Registry record
- NCT07873463 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- BRP-Kendal Lakes
- Registry record
- NCT07589595 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Allied Biomedical Research Institute (ABRI), Inc · South Florida Research Phase I-IV · Sunshine Medical Solution
- Registry record
- NCT06540833 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Advanced Clinical Research Network · Allied Biomedical Research Institute (ABRI), Inc · South Florida Research Phase I-IV
- Registry record
- NCT06651567 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Miami Jewish health
- Registry record
- NCT07011745 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Finlay Medical Research · VIN-Andrew Lerman
- Registry record
- NCT07602582 · updated
[18F]PI-2620 Phase 3 Histopathological Study
- Phase 3
- Ages 50 and older
- All sexes
- Sponsor
- Lantheus Biosciences Ltd.
- Study site
- Miami Jewish Health Systems
- Registry record
- NCT05641688 · updated
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Phase 4
- Ages 50 and older
- All sexes
- Sponsor
- Alpha Cognition, Inc
- Study sites
- Allied Biomedical Research Institute (ABRI), Inc · CCM Clinical Research Group, LLC
- Registry record
- NCT07633470 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study site
- University of Miami
- Registry record
- NCT06563895 · updated
Open-label Extension Study in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07105709 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Miami, FL on ClinicalTrials.gov.
Ask about studies near Miami
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
36 studies recruiting across 45 cities.
Maitland
16 studies recruiting.
Tampa
14 studies recruiting.
Orlando
13 studies recruiting.
Daytona Beach
8 studies recruiting.
Stuart
8 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
Alzheimer's Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections